Compare LUCD & RMAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | LUCD | RMAX |
|---|---|---|
| Founded | 2018 | 1973 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Real Estate |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 159.9M | 125.5M |
| IPO Year | 2021 | 2013 |
| Metric | LUCD | RMAX |
|---|---|---|
| Price | $1.40 | $6.08 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 4 | 1 |
| Target Price | $3.94 | ★ $9.00 |
| AVG Volume (30 Days) | ★ 780.1K | 206.0K |
| Earning Date | 01-01-0001 | 05-18-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 16.67 | N/A |
| EPS | N/A | ★ 0.60 |
| Revenue | $4,346,000.00 | ★ $195,929,000.00 |
| Revenue This Year | $7.69 | $2.62 |
| Revenue Next Year | $155.47 | $1.15 |
| P/E Ratio | ★ N/A | $10.37 |
| Revenue Growth | ★ 79.00 | 11.13 |
| 52 Week Low | $0.95 | $6.01 |
| 52 Week High | $1.80 | $10.32 |
| Indicator | LUCD | RMAX |
|---|---|---|
| Relative Strength Index (RSI) | 57.65 | 27.16 |
| Support Level | $1.01 | N/A |
| Resistance Level | $1.52 | $8.47 |
| Average True Range (ATR) | 0.08 | 0.27 |
| MACD | -0.00 | -0.03 |
| Stochastic Oscillator | 56.52 | 9.34 |
Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically lethal esophageal adenocarcinoma. Its products include EsoCheck and EsoGuard.
RE/MAX Holdings Inc operates as a franchisor of real estate brokerage services. It recruits and retains agents and sells franchises. The company's operating segments include Real Estate, Mortgage, Marketing Funds, and Others. It generates maximum revenue from the Real Estate segment.